Discontinued — last reported Q4 '25
Republic Services Acquisitions increased by 155.6% to $437.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 47.6%, from $834.00M to $437.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 4.0% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $558.60M | $359.70M | $285.40M | $81.60M | $2.57B | $192.60M | $190.90M | $290.90M | $696.80M | $63.40M | $1.01B | $166.30M | $34.70M | $199.40M | $352.60M | $834.00M | $129.00M | $296.00M | $171.00M | $437.00M |
| QoQ Change | — | -35.6% | -20.7% | -71.4% | >999% | -92.5% | -0.9% | +52.4% | +139.5% | -90.9% | >999% | -83.6% | -79.1% | +474.6% | +76.8% | +136.5% | -84.5% | +129.5% | -42.2% | +155.6% |
| YoY Change | — | — | — | — | +360.7% | -46.5% | -33.1% | +256.5% | -72.9% | -67.1% | +431.3% | -42.8% | -95.0% | +214.5% | -65.2% | +401.5% | +271.8% | +48.4% | -51.5% | -47.6% |